Philipp Studt

philipp.studt@lw.com

+32.2.788.6276

Profile

Philipp Studt guides private equity sponsors and public companies through the regulatory aspects of major transactions in the EU and globally.

Philipp draws on extensive cross-border experience to help clients navigate the complex regulatory landscape for transactions including:

Foreign direct investment (FDI) control and screening
Merger control filings and approvals
Regulations on foreign subsidies
Horizontal and vertical agreements
State aid matters

He supports clients in critical sectors, including technology, healthcare, and energy, advising on risk and strategy at the outset of a transaction, culminating in regulatory approval. Philipp has navigated prominent regulatory regimes, including the EU, Austria, Germany, France, Italy, Spain, Canada, and Australia, and co-authored a handbook on FDI control (Handbuch Investitionskontrolle, Manz, June 2022).

Prior to joining Latham, Philipp worked at other international law firms in Brussels and prior to that as a consultant at the World Bank (IFC) in Washington, D.C.

Experience

Philipp’s experience includes advising:

Bunge Limited, a US grains merchant manufacturer, on obtaining FDI approvals in nine jurisdictions globally for its planned US$34 billion merger with rival Viterra
Silver Lake Partners regarding the FDI approvals for the acquisition of Altera
Thermo Fisher regarding the FDI approvals for the acquisition of Solventum
Carlyle regarding the merger control and FDI approvals for the acquisition of Vantive
Triton Partners on FDI clearances across Europe for its acquisition of Trench, the high-voltage component business of Siemens Energy
ECP in relation to the merger control and FDI approvals for the acquisition of Atlantica
Pharma company Norgine Europe on global FDI clearances in relation to its €1.8 billion sale to Goldman Sachs
Syneos Health, a biopharmaceutical solutions organization, on regulatory aspects of its sale to a consortium of private investment firm affiliates
Global shipping company Ocean Network Express on global antitrust clearances for the US$10.9 billion take-private of Atlas Corporation
The Carlyle Group on FDI clearance for the US$6.5 billion sale of Atotech to MKS Instruments
The Binding Site on global merger control and FDI clearances for its £2.25 billion sale to Thermo Fisher
Biotech company Abcam on FDI and merger control clearances for its US$5.7 billion sale to Danaher
Endeavor on antitrust clearance for its US$21 billion acquisition of World Wrestling Entertainment (WWE)
ArchiMed Group on regulatory aspects of its sale of Bomi Italia, an Italy-based healthcare logistics company, to UPS
Various financial and strategic investors in German, EU, and multi-jurisdictional merger control and FDI proceedings, including inter alia The Carlyle Group, KPS Capital*, Bain Capital*, and Public Sector Pension Investment Board*
Linde AG on global merger control and FDI proceedings relating to its merger with Praxair*
ICON on merger control and FDI proceedings relating to its acquisition of PRA Corporation*
Lear Corporation on complex EU merger control proceedings in connection with its acquisition of two seating competitors*